Epoch Biodesign is a UK-based biotechnology company and global leader in enzymatic recycling. Epoch’s ultra-low emission process produces virgin-quality recycled materials from mixed waste streams. By combining artificial intelligence and advanced synthetic biology, Epoch designs enzymes to efficiently recycle end-of-life plastic and textile waste at commercial scale.
Epoch is backed by leading investors, including Lowercarbon Capital, Extantia, lululemon, KOMPAS VC, Inditex (Mundi Ventures) and Leitmotif. They are currently building their second biorecycling facility.
